CD8A and classic Hodgkin lymphoma: Recent evidence is emerging that highlights a lack of β2-microglobulin (B2M) and Major Histocompatibility Complex (MHC) class I at the HRS cell surface in ~90% of cHL cases, which is an essential requirement for an effective CD8+ T cell cytotoxic response [50,51,52].